Projects per year
Personal profile
Area of Expertise
My current research is focused on expanding the chemical toolbox for neural signaling and anti-inflammation/anti-oxidant pathways to help us understand the mechanism of action of the disease pathology associated with glaucomatous optic neuropathy, Alzheimer’s Diseases, Ischemic stroke, and angiogenesis. Our lab integrates medicinal chemistry, chemical biology, bio-engineering, and drug delivery using nanotechnology. We employ synthetic organic and organometallic chemistry to generate a small molecule library for low throughput as well as high throughput screening (target based as well as phenotypic). The ultimate goal of my lab is to produce novel therapeutic molecules which can be progressed to human clinical trials for these diseases.
Education/Academic qualification
PhD in Organic Chemistry, CSIR - Indian Institute of Chemical Technology
Fingerprint
Dive into the research topics where Suchismita Acharya is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 2 Finished
-
-
Evaluation of small molecules in ocular neovascularization (For: Daniel Larson)
5/06/17 → 31/05/18
Project: Research
Research output
-
Nanoencapsulated hybrid compound SA-2 with long-lasting intraocular pressure-lowering activity in rodent eyes
Stankowska, D. L., Millar, J. C., Kodati, B., Behera, S., Chaphalkar, R. M., Nguyen, T., Nguyen, K. T., Krishnamoorthy, R. R., Ellis, D. Z. & Acharya, S., 2021, In: Molecular vision. 27, p. 37-49 13 p.Research output: Contribution to journal › Article › peer-review
-
Small immunomodulatory molecules as potential therapeutics in experimental murine models of acute lung injury (Ali)/acute respiratory distress syndrome (ards)
Shah, D., Das, P., Acharya, S., Agarwal, B., Christensen, D. J., Robertson, S. M. & Bhandari, V., 1 Mar 2021, In: International journal of molecular sciences. 22, 5, p. 1-20 20 p., 2573.Research output: Contribution to journal › Article › peer-review
Open Access -
Small immunomodulatory molecules as potential therapeutics in experimental murine models of acute lung injury (Ali)/acute respiratory distress syndrome (ards)
Shah, D., Das, P., Acharya, S., Agarwal, B., Christensen, D. J., Robertson, S. M. & Bhandari, V., 1 Mar 2021, In: International journal of molecular sciences. 22, 5, p. 1-20 20 p., 2573.Research output: Contribution to journal › Article › peer-review
Open Access -
Erratum: Hybrid compound SA-2 is neuroprotective in animal models of retinal ganglion cell death (Investigative Ophthalmology and Visual Science (2019) 60 (3064–3073) DOI: 10.1167/iovs.18-25999)
Stankowska, D. L., Dibas, A., Li, L., Zhang, W., Krishnamoorthy, V. R., Chavala, S. H., Nguyen, T. P., Yorio, T., Ellis, D. Z. & Acharya, S., 1 Sep 2019, In: Investigative Ophthalmology and Visual Science. 60, 12, p. 3717 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Hybrid compound sa-2 is neuroprotective in animal models of retinal ganglion cell death
Stankowska, D. L., Dibas, A., Li, L., Zhang, W., Krishnamoorthy, V. R., Chavala, S. H., Nguyen, T. P., Yorio, T., Ellis, D. Z. & Acharya, S., Jul 2019, In: Investigative Ophthalmology and Visual Science. 60, 8, p. 3064-3073 10 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations